Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology

BACKGROUND: ALK-rearranged lung cancers exhibit specific pathologic and clinical features and are responsive to anti-ALK therapies. Therefore, the detection of ALK-rearrangement is fundamental for personalized lung cancer therapy. Recently, new molecular techniques, such as NanoString nCounter, have...

Descripción completa

Detalles Bibliográficos
Autores principales: Evangelista, Adriane F., Zanon, Maicon F., Carloni, Adriana Cruvinel, de Paula, Flávia E., Morini, Mariana Andozia, Ferreira-Neto, Maressa, Soares, Iberê Cauduro, Miziara, Jose Elias, de Marchi, Pedro, Scapulatempo-Neto, Cristovam, Reis, Rui M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446704/
https://www.ncbi.nlm.nih.gov/pubmed/28549458
http://dx.doi.org/10.1186/s12890-017-0428-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446704/
https://www.ncbi.nlm.nih.gov/pubmed/28549458
http://dx.doi.org/10.1186/s12890-017-0428-0

Ejemplares similares